A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Recruiting · NCT06546670 · Registry updated 2026-10-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT06546670 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston Childrens Hospital | Boston | United States | 2 |
| Childrens Hospital Of Philadelphia | Philadelphia | United States | 18 |
| East Carolina University | Greenville | United States | 24 |
| Icahn School Of Med At Mount Sinai | New York | United States | 3 |
| Levine Cancer Insitute Carolinas Healthcare System | Charlotte | United States | 2 |
| Lifespan | Providence | United States | 4 |
| Quotient Sciences Sea View | Miami | United States | 2 |
| University of Alabama Birmingham | Birmingham | United States | 16 |
| UT Health Science Center | Houston | United States | 5 |